Nabriva Therapeutics Future Growth

How is Nabriva Therapeutics forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?

Future Growth Score

5/6

Future Growth Score 5/6

60.2%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts

NasdaqCM:NBRV - Analysts future estimates and past financials data (USD Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
12/31/2025	134	16	N/A	N/A	1
12/31/2024	104	-4	N/A	N/A	1
12/31/2023	68	-32	N/A	N/A	2
9/30/2022	36	-47	-41	-41	N/A
6/30/2022	35	-47	-48	-48	N/A
3/31/2022	34	-47	-54	-54	N/A
12/31/2021	29	-49	-60	-60	N/A
9/30/2021	22	-54	-67	-67	N/A
6/30/2021	15	-57	-66	-66	N/A
3/31/2021	7	-60	-65	-65	N/A
12/31/2020	5	-69	-71	-71	N/A
9/30/2020	3	-75	-74	-73	N/A
6/30/2020	9	-80	-76	-76	N/A
3/31/2020	9	-86	-79	-79	N/A
12/31/2019	9	-83	-72	-72	N/A
9/30/2019	10	-91	-79	-79	N/A
6/30/2019	3	-126	-81	-81	N/A
3/31/2019	4	-122	-77	-77	N/A
12/31/2018	10	-115	-73	-73	N/A
9/30/2018	10	-106	-75	-75	N/A
6/30/2018	11	-76	-74	-72	N/A
3/31/2018	11	-72	-72	-71	N/A
12/31/2017	5	-74	-71	-69	N/A
9/30/2017	7	-67	-57	-56	N/A
6/30/2017	6	-59	-54	-53	N/A
3/31/2017	7	-57	-53	-52	N/A
12/31/2016	6	-55	-49	-48	N/A
9/30/2016	5	-67	-42	-41	N/A
6/30/2016	5	-61	N/A	N/A	N/A
3/31/2016	5	-55	N/A	-30	N/A

Earnings vs Savings Rate: NBRV is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2%).

Earnings vs Market: NBRV is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: NBRV is expected to become profitable in the next 3 years.

Revenue vs Market: NBRV's revenue (29% per year) is forecast to grow faster than the US market (7% per year).

High Growth Revenue: NBRV's revenue (29% per year) is forecast to grow faster than 20% per year.

Future ROE: Insufficient data to determine if NBRV's Return on Equity is forecast to be high in 3 years time